Contact

Confluence Health Selects Merge Hemo™ To Maximize Workflow Efficiency merge, merge healthcare, confluence health, merge hemo, hemodynamics, merge cardiology solutions, merge cardio, cath lab software Industry-leading solution delivers real-time documentation to enhance workflow for the cardiac cath lab

Confluence Health Selects Merge Hemo™ to Maximize Workflow Efficiency

Industry-leading solution delivers real-time documentation to enhance workflow for the cardiac cath lab

Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that Confluence Health-Central Washington Hospital & Clinics, has implemented Merge Hemo to automate their cath lab processes. 

“Our old hemo system was causing delays in patient care, so we knew it was time for a change,” explained Derek Bergan, Director of Medical Imaging at Confluence Health. “We already had a solid relationship with Merge because of using their Merge PACS™ solution. Couple that with their high KLAS rankings two years in a row for Merge Hemo, and it was an easy decision. You can’t sustain that level of performance unless you have a good product.”

“We conduct 10-15 cases every day across three cath/EP labs. We selected Merge Hemo because we needed a flexible, stable system that would offer workflow efficiencies,” added Amy Roe, BSN, Cardiac Services Coordinator, at Confluence Health. “We also like the ability to bar code our inventory, which gives us an accurate and documented record of what we use in every case,” added Brian Stevens, RT(R), Lead Technologist at Confluence Health. Confluence Health also liked the fact that Merge Hemo has the ability to capture information through its touch-screen user interface at the point of care and looks forward to integrating it with their Cerner EHR in the near future.

“We are very proud of our Merge Hemo solution, which was ranked #1 in KLAS in both 2011 and 2012. We take KLAS rankings very seriously, and clearly so do providers like Confluence Health,” said Justin Dearborn, CEO of Merge Healthcare. “As an industry leader, we have worked diligently to ensure Merge Hemo exceeds expectations not only in functionality but in training, implementation and support.”

Along with Merge Hemo, the Merge Cardiology suite also includes Merge Cardio™, an enterprise-level image and information system that provides a single point of entry to the patient’s complete cardio record spanning all cardiac modalities.

For more than 20 years, Merge Cardiology Solutions have been developed through a partnership with cardiologists and clinical staff, providing systems and tools with workflow and reporting that physicians are familiar with and comfortable using. This makes adoption of these systems successful, so hospitals, labs and patients can benefit from the efficiencies and cost savings that come from best-of-breed information and imaging solutions.

About Merge
Merge is a leading provider of clinical systems and innovations that seek to transform healthcare.  Merge’s enterprise and cloud-based solutions for image intensive specialties provide access to any image, anywhere, any time. Merge also provides health stations, clinical trials software and other health data and analytics solutions that engage consumers in their personal health. With solutions that are used by providers and consumers and include more than 25 years of innovation, Merge is helping to reduce costs and improve the quality of healthcare worldwide. For more information, visit merge.com.

Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.

Contact:
Jennifer Jawor
Director, Corporate Marketing
312.565.6825
jennifer.jawor@merge.com

 Download this press release >>

© 2017 IBM Watson Health. All Rights Reserved. Privacy | Terms | Email Signup | Sitemap